Skip to main content

CORRECTION article

Front. Immunol., 08 March 2023
Sec. Inflammation
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1163419

Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

This article is a correction to:

  1. Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

    1. Read original article
Xiaolin Zhang,&#x;Xiaolin Zhang1,2†Yi Cai&#x;Yi Cai2†Xu Su&#x;Xu Su2†Quanmin JingQuanmin Jing2Haiwei LiuHaiwei Liu2Kun NaKun Na2Miaohan QiuMiaohan Qiu2Xiaoxiang TianXiaoxiang Tian2Dan LiuDan Liu2Tianxiao WuTianxiao Wu3Chenghui Yan*Chenghui Yan2*Yaling Han,*Yaling Han1,2*
  • 1Second Affiliated Hospital of Dalian Medical University, Dalian, China
  • 2Cardiovascular Research Institute and Department of Cardiology, The General Hospital of Northern Theater Command, Shenyang, China
  • 3Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China

A Corrigendum on
Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction.

By Zhang X, Cai Y, Su X, Jing Q, Liu H, Na K, Qiu M, Tian X, Liu D, Wu T, Yan C and Han Y (2022) Front. Immunol. 13:950441. doi: 10.3389/fimmu.2022.950441

In the published article, there was an error in affiliation 1. Instead of “Department of Cardiology, Dalian Medical College, Dalian, China”, it should be “Second Affiliated Hospital of Dalian Medical University, Dalian, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: ST-acute myocardial infarction, Kynurenine, metabolites, prognosis, biomarker, indoleamine-pyrrole 2,3-dioxygenase

Citation: Zhang X, Cai Y, Su X, Jing Q, Liu H, Na K, Qiu M, Tian X, Liu D, Wu T, Yan C and Han Y (2023) Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction. Front. Immunol. 14:1163419. doi: 10.3389/fimmu.2023.1163419

Received: 10 February 2023; Accepted: 27 February 2023;
Published: 08 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Zhang, Cai, Su, Jing, Liu, Na, Qiu, Tian, Liu, Wu, Yan and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yaling Han, hanyaling@163.net; Chenghui Yan, yanch1029@163.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.